Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 23 studies with search of: | "Mastocytosis" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Recruiting |
Efficacy and Safety of Masitinib (AB1010) in Comparison to Placebo in the Treatment of Patients With Smouldering Systemic, Indolent Systemic or Cutaneous Mastocytosis With Handicap
|
||||
2 | Recruiting |
Cause and Natural Course of Pediatric-Onset Mastocytosis
|
||||
3 | Completed |
Efficacy and Safety of TF002 in Cutaneous Mastocytosis
|
||||
4 | Recruiting |
Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis
|
||||
5 | Completed |
Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals
|
||||
6 | Completed |
Characteristics of Mast Cells in Mastocytosis
|
||||
7 | Completed |
Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing
|
||||
8 | Recruiting |
Therapy of HES, PV, Atypical CML or CMML, and Mastocytosis With Imatinib Mesylate
|
||||
9 | Recruiting |
Molecular Mechanisms and Diagnosis of Mastocytosis
|
||||
10 | Completed |
Stem Cell Transplantation to Treat Systemic Mastocytosis
|
||||
11 | Recruiting |
Phase II PKC412 in Aggressive Systemic Mastocytosis and Mast Cell Leukemia
|
||||
12 | Completed |
Ontak (Denileukin Diftitox) in Patients With SM
|
||||
13 | Active, not recruiting |
Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)
|
||||
14 | Recruiting |
Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes
|
||||
15 | Recruiting |
Study of Factors Regulating Mast Cell Proliferation
|
||||
16 | Recruiting |
Study of Mast Cell Precursors
|
||||
17 | Active, not recruiting |
A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Blood Related Cancers
|
||||
18 | Recruiting |
Thalidomide in Treating Patients With Relapsed or Progressive Systemic Mastocytosis
|
||||
19 | Recruiting |
Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
|
||||
20 | Completed |
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis
|
Previous Page | Studies Shown (1-20) | Next (21-23) |